711 related articles for article (PubMed ID: 22902876)
1. A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance.
Ito K; Carracedo A; Weiss D; Arai F; Ala U; Avigan DE; Schafer ZT; Evans RM; Suda T; Lee CH; Pandolfi PP
Nat Med; 2012 Sep; 18(9):1350-8. PubMed ID: 22902876
[TBL] [Abstract][Full Text] [Related]
2. A ROSy future for metabolic regulation of HSC division.
Broxmeyer HE; Mantel C
Nat Med; 2012 Sep; 18(9):1334-6. PubMed ID: 22961159
[No Abstract] [Full Text] [Related]
3. A metabolic prosurvival role for PML in breast cancer.
Carracedo A; Weiss D; Leliaert AK; Bhasin M; de Boer VC; Laurent G; Adams AC; Sundvall M; Song SJ; Ito K; Finley LS; Egia A; Libermann T; Gerhart-Hines Z; Puigserver P; Haigis MC; Maratos-Flier E; Richardson AL; Schafer ZT; Pandolfi PP
J Clin Invest; 2012 Sep; 122(9):3088-100. PubMed ID: 22886304
[TBL] [Abstract][Full Text] [Related]
4. The role of PML in hematopoietic and leukemic stem cell maintenance.
Nakahara F; Weiss CN; Ito K
Int J Hematol; 2014 Jul; 100(1):18-26. PubMed ID: 24488785
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes.
Robciuc MR; Skrobuk P; Anisimov A; Olkkonen VM; Alitalo K; Eckel RH; Koistinen HA; Jauhiainen M; Ehnholm C
PLoS One; 2012; 7(10):e46212. PubMed ID: 23056264
[TBL] [Abstract][Full Text] [Related]
6. Self-renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance.
Ito K; Turcotte R; Cui J; Zimmerman SE; Pinho S; Mizoguchi T; Arai F; Runnels JM; Alt C; Teruya-Feldstein J; Mar JC; Singh R; Suda T; Lin CP; Frenette PS; Ito K
Science; 2016 Dec; 354(6316):1156-1160. PubMed ID: 27738012
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy.
Cheng L; Ding G; Qin Q; Huang Y; Lewis W; He N; Evans RM; Schneider MD; Brako FA; Xiao Y; Chen YE; Yang Q
Nat Med; 2004 Nov; 10(11):1245-50. PubMed ID: 15475963
[TBL] [Abstract][Full Text] [Related]
8. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
[TBL] [Abstract][Full Text] [Related]
9. Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood Samples.
Sibille B; Mothe-Satney I; Le Menn G; Lepouse D; Le Garf S; Baudoin E; Murdaca J; Moratal C; Lamghari N; Chinetti G; Neels JG; Rousseau AS
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768927
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
[TBL] [Abstract][Full Text] [Related]
11. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A.
Faulkner A; Lynam E; Purcell R; Jones C; Lopez C; Board M; Wagner KD; Wagner N; Carr C; Wheeler-Jones C
Sci Rep; 2020 May; 10(1):7849. PubMed ID: 32398728
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
13. mTORC1 signaling governs hematopoietic stem cell quiescence.
Gan B; DePinho RA
Cell Cycle; 2009 Apr; 8(7):1003-6. PubMed ID: 19270523
[TBL] [Abstract][Full Text] [Related]
14. Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs.
Park SM; Deering RP; Lu Y; Tivnan P; Lianoglou S; Al-Shahrour F; Ebert BL; Hacohen N; Leslie C; Daley GQ; Lengner CJ; Kharas MG
J Exp Med; 2014 Jan; 211(1):71-87. PubMed ID: 24395885
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain.
Yu S; Levi L; Casadesus G; Kunos G; Noy N
J Biol Chem; 2014 May; 289(18):12748-58. PubMed ID: 24644281
[TBL] [Abstract][Full Text] [Related]
16. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
17. High-fat feeding in cardiomyocyte-restricted PPARdelta knockout mice leads to cardiac overexpression of lipid metabolic genes but fails to rescue cardiac phenotypes.
Li Y; Cheng L; Qin Q; Liu J; Lo WK; Brako LA; Yang Q
J Mol Cell Cardiol; 2009 Oct; 47(4):536-43. PubMed ID: 19595695
[TBL] [Abstract][Full Text] [Related]
18. PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction.
Ravnskjaer K; Frigerio F; Boergesen M; Nielsen T; Maechler P; Mandrup S
J Lipid Res; 2010 Jun; 51(6):1370-9. PubMed ID: 19965574
[TBL] [Abstract][Full Text] [Related]
19. FANCD2 and HES1 suppress inflammation-induced PPARɣ to prevent haematopoietic stem cell exhaustion.
Wu L; Li X; Lin Q; Chowdhury F; Mazumder MH; Du W
Br J Haematol; 2021 Feb; 192(3):652-663. PubMed ID: 33222180
[TBL] [Abstract][Full Text] [Related]
20. The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.
Liu X; Yuan H; Peres L; Chen S; Chen Z; de The H; Zhou J; Zhu J
PLoS One; 2014; 9(8):e104906. PubMed ID: 25119106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
